March 2, 2026: Gastrointestinal Lawsuits Involving Trulicity, Other GLP-1s Increase in March Eli Lilly and one other drug company are facing 3,363 lawsuits in a consolidated MDL, in which plaintiffs accuse the companies of failing to warn patients about the gastrointestinal risks of taking Trulicity and other GLP-1s
New formulations, regulatory evaluations, and continuous clinical trials will probably shape future peptide treatment
That single sentence deserves emphasis
A 2024 TikTok algorithm study , conducted by researchers at the University of Melbourne, found that users with a history of disordered eating were served more videos featuring "toxic" eating disorder content than those without prior struggles
All of the known key hGLP-1 residues (underlined in Fig
As a result, these less-expensive weight loss drug alternatives remain available, though experts remain concerned about their safety and efficacy